S
Sara Trabulo
Researcher at Queen Mary University of London
Publications - 26
Citations - 1559
Sara Trabulo is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Pancreatic cancer & Cancer stem cell. The author has an hindex of 18, co-authored 26 publications receiving 1314 citations. Previous affiliations of Sara Trabulo include Bayer & University of Coimbra.
Papers
More filters
Journal ArticleDOI
Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems
TL;DR: The current knowledge of the mechanisms responsible for the cellular uptake of cell-penetrating peptides, including the S413-PV peptide, are discussed, and the potential of peptide-based formulations to mediate nucleic acid delivery is discussed.
Journal ArticleDOI
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
Michele Cioffi,Sara Trabulo,Manuel Hidalgo,Eithne Costello,William Greenhalf,Mert Erkan,Mert Erkan,J. Kleeff,Bruno Sainz,Christopher Heeschen +9 more
TL;DR: Targeting CD47 efficiently enhanced phagocytosis of a representative set of primary pancreatic cancer (stem) cells and also directly induced their apoptosis in the absence of macrophages during long-term inhibition of CD47 strongly suggest that CD47 inhibition could be a novel adjuvant treatment strategy for PDAC independent of underlying and highly variable driver mutations.
Journal ArticleDOI
Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells.
Enza Lonardo,Michele Cioffi,Patricia Sancho,Yolanda Sanchez-Ripoll,Sara Trabulo,Jorge Dorado,Anamaria Balic,Manuel Hidalgo,Christopher Heeschen +8 more
TL;DR: It is demonstrated that metformin selectively ablated pancreatic CSCs as evidenced by diminished expression of pluripotency-associated genes and CSC-associated surface markers, which effectively reduced tumor burden and prevented disease progression in primary cancer tissue xenograft models.
Journal ArticleDOI
Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling
Anamaria Balic,Morten Dræby Sørensen,Sara Trabulo,Bruno Sainz,Michele Cioffi,Catarina R. Vieira,Irene Miranda-Lorenzo,Manuel Hidalgo,J. Kleeff,Mert Erkan,Christopher Heeschen +10 more
TL;DR: This study demonstrates that via to date unreported effects, chloroquine is an effective adjuvant therapy to chemotherapy, offering more efficient tumor elimination and improved cure rates.
Journal ArticleDOI
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells
Michele Cioffi,Sara Trabulo,Yolanda Sanchez-Ripoll,Irene Miranda-Lorenzo,Enza Lonardo,Jorge Dorado,Catarina R. Vieira,Juan C. Ramirez,Manuel Hidalgo,Alexandra Aicher,Stephan A. Hahn,Bruno Sainz,Christopher Heeschen +12 more
TL;DR: The miR-17-92 cluster is identified as a functionally determining family of miRNAs in CSCs, and the putative potential of developing modulators of this cluster to overcome drug resistance in pancreatic C SCs is highlighted.